
Sign up to save your podcasts
Or
Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.
4.2
4444 ratings
Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.
216 Listeners
135 Listeners
229 Listeners
185 Listeners
26 Listeners
24 Listeners
27 Listeners
1,964 Listeners
6 Listeners
5 Listeners
104 Listeners
0 Listeners
5 Listeners
8 Listeners
3,511 Listeners